Novavax (NVAX) Tops Q2 EPS by 8c

Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.32), $0.08 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $57 million versus the consensus estimate of $52.06 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Dollar Tree stock falls despite earnings beat
• Fed’s Collins sees mixed inflation data, remains open to rate hikes